Who
John E. Gallina
Director
Company insider
Files Form 4 as: Director, Arrive AI; Director, CVS Health; EVP & Chief Financial Officer, Elevance Health.
In numbers
- Trades disclosed
- 149
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $37.9M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 2 Sep 2008
- Last trade
- 2 Oct 2026
- Last filed
- 9 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Oct 2026filed 9 Oct 2026 | ARAI Arrive AIoption or derivative · Business Services | SEC FORM 4 Code A | —172,811 at $0.00 | filing |
| 6 Jul 2026filed 7 Jul 2026 | ARAI Arrive AIoption or derivative · Business Services | SEC FORM 4 Code A | —87,413 at $0.00 | filing |
| 6 Jul 2026filed 7 Jul 2026 | ARAI Arrive AIoption or derivative · Business Services | SEC FORM 4 Code A | —87,413 at $0.00 | filing |
| 14 May 2026filed 15 May 2026 | CVS CVS Healthoption or derivative · Mass, Grocery & Drug Retail | SEC FORM 4 Code A | $141K1,447.504 at $97.15 | filing |
| 14 May 2026filed 15 May 2026 | CVS CVS Healthoption or derivative · Mass, Grocery & Drug Retail | SEC FORM 4 Code A | $141K1,447.5 at $97.15 | filing |
| 31 Mar 2026filed 2 Apr 2026 | ARAI Arrive AIoption or derivative · Business Services | SEC FORM 4 Code A | —47,052 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | ARAI Arrive AIoption or derivative · Business Services | SEC FORM 4 Code A | —47,052 at $0.00 | filing |
| 19 Mar 2026filed 20 Mar 2026 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Code A | $42K582 at $71.86 | filing |
| 19 Mar 2026filed 20 Mar 2026 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Code A | $42K582 at $71.86 | filing |
| 31 Dec 2025filed 5 Jan 2026 | ARAI Arrive AIoption or derivative · Business Services | SEC FORM 4 Code A | —14,259 at $0.00 | filing |
| 31 Dec 2025filed 5 Jan 2026 | ARAI Arrive AIoption or derivative · Business Services | SEC FORM 4 Code A | —14,259 at $0.00 | filing |
| 6 Oct 2025filed 20 Oct 2025 | ARAI Arrive AIoption or derivative · Business Services | SEC FORM 4 Code A | —7,292 at $0.00 | filing |
| 6 Oct 2025filed 8 Oct 2025 | ARAI Arrive AIBusiness Services | SEC FORM 4 Code A | —7,292 at $0.00 | filing |
| 30 Jun 2025filed 3 Sep 2025 | ARAI Arrive AIBusiness Services | SEC FORM 4 Code A | —856 at $0.00 | filing |
| 23 Jun 2025filed 3 Sep 2025 | ARAI Arrive AIBusiness Services | SEC FORM 4 Code A | —7,693 at $0.00 | filing |
| 2 Mar 2023filed 3 Mar 2023 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code F | $2.2M4,650 at $468.78 | filing |
| 1 Mar 2023filed 3 Mar 2023 | ELV Elevance Healthoption or derivative · Managed Care & Insurers | SEC FORM 4 Code A | —11,782 at $0.00 | filing |
| 1 Mar 2023filed 3 Mar 2023 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code F | $275K587 at $469.03 | filing |
| 1 Mar 2023filed 3 Mar 2023 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code A | —3,065 at $0.00 | filing |
| 1 Mar 2023filed 3 Mar 2023 | ELV Elevance HealthManaged Care & Insurers | SEC FORM 4 Code A | —9,716 at $0.00 | filing |
News
Elevance Health Raises 2026 Outlook As Third-Quarter Profit Tops Prior YearELV · rttnews.com · 21 Oct 2026Elevance Health reaches $425.27, completing a full-year round tripELV · 247wallst.com · 14 Oct 2026Elevance Health (NYSE:ELV) Given New $460.00 Price Target at GuggenheimELV · themarketsdaily.com · 13 Oct 2026
0 headlines in the last 90 days name John E. Gallina; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.